OTC: PPCB - Propanc Biopharma, Inc.

Lønnsomhet i seks måneder: -80.45%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Propanc Biopharma, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Propanc Biopharma, Inc.

Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes.

flere detaljer
The company has a research collaboration with University of Jaén that undertakes the research activities for POP1 joint drug discovery program; and a joint research and drug discovery program with Universities of Jaén and Granada to investigate the changes in genetic and protein expression that occur in cancer cells. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

ISIN US74346N4043
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.propanc.com
Цена ао 5.75
Prisendring per dag: 0% (5.75)
Prisendring per uke: -35.32% (8.89)
Prisendring per måned: -77% (25)
Prisendring over 3 måneder: -51.12% (11.7647)
Prisendring over seks måneder: -80.45% (29.4118)
Prisendring per år: +179 587.5% (0.0032)
Prisendring over 3 år: +29 692.75% (0.0193)
Prisendring over 5 år: +3 571.78% (0.1566)
Prisendring over 10 år: 0% (5.75)
Prisendring siden begynnelsen av året: -51.12% (11.7647)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV -1456.17 0
P/E 0 0
EV/EBITDA -3583.13 0
Total: 0.25

Effektivitet

Navn Betydning Karakter
ROA, % -2743.97 0
ROE, % 52.8 10
Total: 3.33

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.6173 10
Total: 6

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % -50.45 0
Lønnsomhet EPS, % -99.88 0
Total: 0
Flere detaljer



Veileder Stillingstittel Betaling Fødselsår
Mr. James Nathanielsz Executive Chairman, CEO, CFO, Treasurer & Secretary 430.28k 1974 (51 år)
Dr. Julian Norman Kenyon ChB, M.D., MB Chief Scientific Officer, CTO & Director 35.99k 1948 (77 år)
Prof. Klaus Kutz Chief Medical Officer & Member of Scientific Advisory Board 18.23k

Adresse: Australia, Camberwell. VIC, 302. 6 Butler Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.propanc.com